124 related articles for article (PubMed ID: 19744481)
1. Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model.
Gaspar RC; Villarreal SA; Bowles N; Hepler RW; Joyce JG; Shughrue PJ
Exp Neurol; 2010 Jun; 223(2):394-400. PubMed ID: 19744481
[TBL] [Abstract][Full Text] [Related]
2. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
3. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J
J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032
[TBL] [Abstract][Full Text] [Related]
4. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease.
Wang L; Sato H; Zhao S; Tooyama I
Neurosci Lett; 2010 Sep; 481(3):164-7. PubMed ID: 20599473
[TBL] [Abstract][Full Text] [Related]
5. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
6. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease.
Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN
Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562
[TBL] [Abstract][Full Text] [Related]
7. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
8. The bad seed in Alzheimer's disease.
Fryer JD; Holtzman DM
Neuron; 2005 Jul; 47(2):167-8. PubMed ID: 16039556
[TBL] [Abstract][Full Text] [Related]
9. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
Ha C; Ryu J; Park CB
Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
[TBL] [Abstract][Full Text] [Related]
10. Abeta-globulomers are formed independently of the fibril pathway.
Gellermann GP; Byrnes H; Striebinger A; Ullrich K; Mueller R; Hillen H; Barghorn S
Neurobiol Dis; 2008 May; 30(2):212-20. PubMed ID: 18353662
[TBL] [Abstract][Full Text] [Related]
11. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template.
Ha C; Park CB
Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248
[TBL] [Abstract][Full Text] [Related]
12. Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition.
Li Q; Gordon M; Etienne MA; Hammer RP; Morgan D
Cell Transplant; 2008; 17(4):397-408. PubMed ID: 18522242
[TBL] [Abstract][Full Text] [Related]
13. Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations.
Tseng BP; Esler WP; Clish CB; Stimson ER; Ghilardi JR; Vinters HV; Mantyh PW; Lee JP; Maggio JE
Biochemistry; 1999 Aug; 38(32):10424-31. PubMed ID: 10441137
[TBL] [Abstract][Full Text] [Related]
14. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F
Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840
[TBL] [Abstract][Full Text] [Related]
15. Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease.
Mohajeri MH; Kuehnle K; Li H; Poirier R; Tracy J; Nitsch RM
FEBS Lett; 2004 Mar; 562(1-3):16-21. PubMed ID: 15043995
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models.
van Groen T; Kadish I; Wiesehan K; Funke SA; Willbold D
ChemMedChem; 2009 Feb; 4(2):276-82. PubMed ID: 19072935
[TBL] [Abstract][Full Text] [Related]
17. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
Schwab C; Hosokawa M; McGeer PL
Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802
[TBL] [Abstract][Full Text] [Related]
19. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
